vs

Side-by-side financial comparison of DANA Inc (DAN) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

DANA Inc is the larger business by last-quarter revenue ($1.3B vs $719.4M, roughly 1.8× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs -3.9%, a 77.0% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -44.5%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $345.0M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs -31.2%).

Dana Incorporated is an American supplier of axles, driveshafts, and electrodynamic, thermal, sealing, and digital equipment for conventional, hybrid, and electric-powered vehicles. The company's products and services are aimed at the light vehicle and commercial vehicle equipment markets. Founded in 1904 and based in Maumee, Ohio, the company employs nearly 28,000 people in 33 countries. In 2022, Dana generated sales of $10.2 billion. The company is included in the Fortune 500.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

DAN vs DOC — Head-to-Head

Bigger by revenue
DAN
DAN
1.8× larger
DAN
$1.3B
$719.4M
DOC
Growing faster (revenue YoY)
DOC
DOC
+47.6% gap
DOC
3.1%
-44.5%
DAN
Higher net margin
DOC
DOC
77.0% more per $
DOC
73.2%
-3.9%
DAN
More free cash flow
DOC
DOC
$12.0M more FCF
DOC
$357.0M
$345.0M
DAN
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
-31.2%
DAN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DAN
DAN
DOC
DOC
Revenue
$1.3B
$719.4M
Net Profit
$-50.0M
$114.0M
Gross Margin
6.0%
Operating Margin
-0.2%
17.4%
Net Margin
-3.9%
73.2%
Revenue YoY
-44.5%
3.1%
Net Profit YoY
37.5%
2406.4%
EPS (diluted)
$-0.36
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DAN
DAN
DOC
DOC
Q4 25
$1.3B
$719.4M
Q3 25
$1.9B
$705.9M
Q2 25
$1.9B
$694.3M
Q1 25
$2.4B
$702.9M
Q4 24
$2.3B
$698.0M
Q3 24
$2.5B
$700.4M
Q2 24
$2.7B
$695.5M
Q1 24
$2.7B
$606.6M
Net Profit
DAN
DAN
DOC
DOC
Q4 25
$-50.0M
$114.0M
Q3 25
$83.0M
$-117.1M
Q2 25
$27.0M
$31.7M
Q1 25
$25.0M
$42.8M
Q4 24
$-80.0M
$4.5M
Q3 24
$4.0M
$85.9M
Q2 24
$16.0M
$146.0M
Q1 24
$3.0M
$6.7M
Gross Margin
DAN
DAN
DOC
DOC
Q4 25
6.0%
Q3 25
8.7%
58.6%
Q2 25
7.1%
60.2%
Q1 25
9.4%
61.1%
Q4 24
5.7%
60.3%
Q3 24
9.9%
60.0%
Q2 24
9.3%
60.6%
Q1 24
8.9%
59.8%
Operating Margin
DAN
DAN
DOC
DOC
Q4 25
-0.2%
17.4%
Q3 25
2.8%
9.2%
Q2 25
0.8%
5.7%
Q1 25
3.1%
7.7%
Q4 24
-1.5%
-2.2%
Q3 24
3.6%
14.1%
Q2 24
3.8%
22.3%
Q1 24
2.6%
3.7%
Net Margin
DAN
DAN
DOC
DOC
Q4 25
-3.9%
73.2%
Q3 25
4.3%
-16.6%
Q2 25
1.4%
4.6%
Q1 25
1.1%
6.1%
Q4 24
-3.4%
0.7%
Q3 24
0.2%
12.3%
Q2 24
0.6%
21.0%
Q1 24
0.1%
1.1%
EPS (diluted)
DAN
DAN
DOC
DOC
Q4 25
$-0.36
$0.16
Q3 25
$0.64
$-0.17
Q2 25
$0.19
$0.05
Q1 25
$0.17
$0.06
Q4 24
$-0.55
$0.02
Q3 24
$0.03
$0.12
Q2 24
$0.11
$0.21
Q1 24
$0.02
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DAN
DAN
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$469.0M
$467.5M
Total DebtLower is stronger
$2.6B
$9.8B
Stockholders' EquityBook value
$840.0M
$7.5B
Total Assets
$7.8B
$20.3B
Debt / EquityLower = less leverage
3.05×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DAN
DAN
DOC
DOC
Q4 25
$469.0M
$467.5M
Q3 25
$414.0M
$91.0M
Q2 25
$486.0M
$89.4M
Q1 25
$507.0M
$70.6M
Q4 24
$494.0M
$119.8M
Q3 24
$419.0M
$180.4M
Q2 24
$419.0M
$106.9M
Q1 24
$351.0M
$101.8M
Total Debt
DAN
DAN
DOC
DOC
Q4 25
$2.6B
$9.8B
Q3 25
$2.6B
$9.1B
Q2 25
$2.6B
$9.0B
Q1 25
$2.4B
$8.9B
Q4 24
$2.4B
$8.7B
Q3 24
$2.4B
$8.6B
Q2 24
$2.4B
$8.6B
Q1 24
$2.6B
$8.8B
Stockholders' Equity
DAN
DAN
DOC
DOC
Q4 25
$840.0M
$7.5B
Q3 25
$1.1B
$7.6B
Q2 25
$1.2B
$7.9B
Q1 25
$1.4B
$8.2B
Q4 24
$1.3B
$8.4B
Q3 24
$1.5B
$8.6B
Q2 24
$1.5B
$8.8B
Q1 24
$1.5B
$8.9B
Total Assets
DAN
DAN
DOC
DOC
Q4 25
$7.8B
$20.3B
Q3 25
$8.1B
$19.6B
Q2 25
$8.1B
$19.8B
Q1 25
$7.8B
$19.8B
Q4 24
$7.5B
$19.9B
Q3 24
$7.9B
$20.0B
Q2 24
$7.8B
$20.2B
Q1 24
$7.9B
$20.5B
Debt / Equity
DAN
DAN
DOC
DOC
Q4 25
3.05×
1.31×
Q3 25
2.35×
1.20×
Q2 25
2.13×
1.14×
Q1 25
1.76×
1.08×
Q4 24
1.79×
1.04×
Q3 24
1.65×
1.00×
Q2 24
1.62×
0.98×
Q1 24
1.68×
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DAN
DAN
DOC
DOC
Operating Cash FlowLast quarter
$406.0M
$1.3B
Free Cash FlowOCF − Capex
$345.0M
$357.0M
FCF MarginFCF / Revenue
26.6%
49.6%
Capex IntensityCapex / Revenue
4.7%
124.4%
Cash ConversionOCF / Net Profit
10.99×
TTM Free Cash FlowTrailing 4 quarters
$298.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DAN
DAN
DOC
DOC
Q4 25
$406.0M
$1.3B
Q3 25
$111.0M
$315.0M
Q2 25
$32.0M
$363.5M
Q1 25
$-37.0M
$279.4M
Q4 24
$302.0M
$1.1B
Q3 24
$35.0M
$318.2M
Q2 24
$215.0M
$316.2M
Q1 24
$-102.0M
$152.6M
Free Cash Flow
DAN
DAN
DOC
DOC
Q4 25
$345.0M
$357.0M
Q3 25
$62.0M
Q2 25
$3.0M
Q1 25
$-112.0M
Q4 24
$149.0M
$333.7M
Q3 24
$-11.0M
Q2 24
$104.0M
Q1 24
$-172.0M
FCF Margin
DAN
DAN
DOC
DOC
Q4 25
26.6%
49.6%
Q3 25
3.2%
Q2 25
0.2%
Q1 25
-4.8%
Q4 24
6.4%
47.8%
Q3 24
-0.4%
Q2 24
3.8%
Q1 24
-6.3%
Capex Intensity
DAN
DAN
DOC
DOC
Q4 25
4.7%
124.4%
Q3 25
2.6%
Q2 25
1.5%
Q1 25
3.2%
Q4 24
6.6%
105.6%
Q3 24
1.9%
Q2 24
4.1%
Q1 24
2.6%
Cash Conversion
DAN
DAN
DOC
DOC
Q4 25
10.99×
Q3 25
1.34×
Q2 25
1.19×
11.48×
Q1 25
-1.48×
6.52×
Q4 24
235.43×
Q3 24
8.75×
3.71×
Q2 24
13.44×
2.17×
Q1 24
-34.00×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DAN
DAN

Light Vehicle Segment$912.0M70%
Commercial Vehicle Segment$218.0M17%
Other$166.0M13%

DOC
DOC

Segment breakdown not available.

Related Comparisons